Risultati della ricerca - Marie‐Christine Etienne‐Grimaldi
- Mostra 1 - 17 risultati su 17
-
1
Pharmacological background of EGFR targeting di Lesley Castillo, Marie‐Christine Etienne‐Grimaldi, Jean–Louis Fischel, Patricia Formento, Nicolas Magné, G. Milano
Pubblicazione 2004Revisão -
2
-
3
Phase II Trial of Bevacizumab in Combination With Temozolomide as First-Line Treatment in Patients With Metastatic Uveal Melanoma di Sophie Piperno‐Neumann, Alhassane Diallo, Marie‐Christine Etienne‐Grimaldi, François‐Clément Bidard, Manuel Rodrigues, Corine Plancher, Pascale Mariani, Nathalie Cassoux, Didier Decaudin, Bernard Asselain, Vincent Servois
Pubblicazione 2016Artigo -
4
Pharmacogenetic profiling and cetuximab outcome in patients with advanced colorectal cancer di Laëtitia Dahan, Emmanuelle Norguet, Marie‐Christine Etienne‐Grimaldi, Jean–Louis Formento, Mohamed Gasmi, Isabelle Nanni, Jean Gaudart, Stéphane Garcia, L’Houcine Ouafik, Jean‐François Seitz, G. Milano
Pubblicazione 2011Artigo -
5
Clinical value of circulating endothelial cells and circulating tumor cells in metastatic breast cancer patients treated first line with bevacizumab and chemotherapy di François‐Clément Bidard, Claire Mathiot, Armelle Degeorges, Marie‐Christine Etienne‐Grimaldi, R. Delva, Xavier Pivot, Corinne Veyret, Laurence Bergougnoux, Patricia de Crémoux, G. Milano, Jean‐Yves Pierga
Pubblicazione 2010Artigo -
6
Current diagnostic and clinical issues of screening for dihydropyrimidine dehydrogenase deficiency di Marie‐Christine Etienne‐Grimaldi, Nicolas Pallet, Valérie Boige, Joseph Ciccolini, Laurent Chouchana, Chantal Barin‐Le Guellec, Aziz Zaanan, Céline Narjoz, Julien Taı̈eb, Fabienne Thomas, Marie‐Anne Loriot
Pubblicazione 2022Revisão -
7
<i>ERCC1</i> and <i>ERCC2</i> Polymorphisms Predict Clinical Outcomes of Oxaliplatin-Based Chemotherapies in Gastric and Colorectal Cancer: A Systemic Review and Meta-analysis di Ming Yin, Jingrong Yan, Eva Martinez‐Balibrea, Francesco Graziano, Heinz‐Josef Lenz, Hyo-Jin Kim, Jacques Robert, Seock‐Ah Im, Wei-Shu Wang, Marie-Christine Etienne-Grimaldi, Qingyi Wei
Pubblicazione 2011Revisão -
8
Toxicities associated with chemotherapy regimens containing a fluoropyrimidine: A real-life evaluation in France di Chantal Barin‐Le Guellec, Claire Lafay‐Chebassier, Isabelle Ingrand, Jean‐François Tournamille, Adeline Boudet, Mary-Christine Lanoue, Gautier Défossez, Pierre Ingrand, Marie‐Christine Pérault‐Pochat, Marie‐Christine Etienne‐Grimaldi
Pubblicazione 2019Artigo -
9
Methylenetetrahydrofolate reductase (MTHFR) gene polymorphisms and FOLFOX response in colorectal cancer patients di Marie‐Christine Etienne‐Grimaldi, G. Milano, Frédérique Maindrault‐Gœbel, Benoist Chibaudel, Jean‐Louis Formento, M Francoual, Gérard Lledo, Thierry André, May Mabro, Laurent Mineur, M. Flesch, Élisabeth Carola, Aimery de Gramont
Pubblicazione 2009Artigo -
10
Pharmacogenetics of Capecitabine in Advanced Breast Cancer Patients di Rémy Largillier, Marie‐Christine Etienne‐Grimaldi, Jean–Louis Formento, Joseph Ciccolini, Jean-François Nebbia, A. Ginot, M Francoual, N. Renée, Jean-Marc Ferrero, Cyril Foa, Moïse Namer, Bruno Lacarelle, G. Milano
Pubblicazione 2006Artigo -
11
Prospective analysis of the impact of <i>VEGF‐A</i> gene polymorphisms on the pharmacodynamics of bevacizumab‐based therapy in metastatic breast cancer patients di Marie‐Christine Etienne‐Grimaldi, Patricia Formento, Armelle Degeorges, Jean‐Yves Pierga, R. Delva, Xavier Pivot, Florence Dalenc, Marc Espié, Corinne Veyret, Jean‐Louis Formento, M Francoual, M. Piutti, Patricia de Crémoux, G. Milano
Pubblicazione 2010Artigo -
12
K-Ras Mutations and Treatment Outcome in Colorectal Cancer Patients Receiving Exclusive Fluoropyrimidine Therapy di Marie‐Christine Etienne‐Grimaldi, Jean–Louis Formento, M Francoual, Éric François, Patricia Formento, N. Renée, Pierre Laurent‐Puig, M Chazal, Daniel Benchimol, Jean‐Robert Delpéro, Christian Létoublon, Denis Pezet, Jean‐François Seitz, G. Milano
Pubblicazione 2008Artigo -
13
Intragenic deletions and a deep intronic mutation affecting pre-mRNA splicing in the dihydropyrimidine dehydrogenase gene as novel mechanisms causing 5-fluorouracil toxicity di André B. P. Kuilenburg, Judith Meijer, Adri N. Mul, Rutger Meinsma, Veronika Schmid, Doreen Dobritzsch, Raoul C. M. Hennekam, Marcel M.A.M. Mannens, Marion Kiechle, Marie‐Christine Etienne‐Grimaldi, Heinz‐Josef Klümpen, Jan Gerard Maring, Veerle A. Derleyn, Ed Maartense, G. Milano, Raymon Vijzelaar, Eva Groß
Pubblicazione 2010Artigo -
14
Gene Expression Classification of Colon Cancer into Molecular Subtypes: Characterization, Validation, and Prognostic Value di Laëtitia Marisa, Aurélien de Reyniès, Alex Duval, Janick Sèlves, Marie Pierre Gaub, Laure Vescovo, Marie‐Christine Etienne‐Grimaldi, Renaud Schiappa, Dominique Guénot, Mira Ayadi, Sylvain Kirzin, M Chazal, Jean–François Fléjou, Daniel Benchimol, Anne Berger, Arnaud Lagarde, Erwan Pencreach, F Piard, Dominique Élias, Yann Parc, Sylviane Olschwang, G. Milano, Pierre Laurent‐Puig, Valérie Boige
Pubblicazione 2013Artigo -
15
Dépistage du déficit en dihydropyrimidine déshydrogénase (DPD) et sécurisation des chimiothérapies à base de fluoropyrimidines : mise au point et recommandations nationales du GPCO... di Marie‐Anne Loriot, Joseph Ciccolini, Fabienne Thomas, Chantal Barin‐Le Guellec, Bernard Royer, G. Milano, Nicolas Picard, Laurent Becquemont, Céline Verstuyft, Céline Narjoz, Antonin Schmitt, Christine Bobin‐Dubigeon, Alexandre Harlé, Angélo Paci, Vianney Poinsignon, Sylvie Quaranta, Alexandre Evrard, Benjamin Hennart, Franck Broly, Xavier Fonrose, Claire Lafay‐Chebassier, Anne‐Sophie Wozny, Fadil Masskouri, Jean-Christophe Boyer, Marie‐Christine Etienne‐Grimaldi
Pubblicazione 2018Revisão -
16
New advances in DPYD genotype and risk of severe toxicity under capecitabine di Marie‐Christine Etienne‐Grimaldi, Jean-Christophe Boyer, Christophe Béroud, Litaty Mbatchi, André B. P. Kuilenburg, Christine Bobin‐Dubigeon, Fabienne Thomas, Étienne Chatelut, Jean‐Louis Merlin, Frédéric Pinguet, Christophe Ferrand, Judith Meijer, Alexandre Evrard, Laurence Llorca, Gilles Romieu, Philippe Follana, Thomas Bachelot, L. Chaigneau, Xavier Pivot, Véronique Dièras, Rémy Largillier, Mireille Mousseau, Anthony Gonçalves, Henri Roché, Jacques Bonneterre, V. Servent, Nadine Dohollou, Y. Château, Emmanuel Chamorey, Jean-Pierre Desvignes, David Salgado, Jean-Marc Ferrero, G. Milano
Pubblicazione 2017Artigo -
17
Genetic Markers of Toxicity From Capecitabine and Other Fluorouracil-Based Regimens: Investigation in the QUASAR2 Study, Systematic Review, and Meta-Analysis di Dan Rosmarin, Claire Palles, David N. Church, Enric Domingo, Angela Jones, Elaine Johnstone, Haitao Wang, Sharon Love, Patrick Julier, Claire Scudder, Geoffrey C. Nicholson, Anna González‐Neira, Miguel Martín, Daniel J. Sargent, Erin Green, Howard L. McLeod, Ulrich M. Zanger, Matthias Schwab, Michael Braun, Michel Seymour, Lindsay C Thompson, Benjamin Lacas, Valérie Boige, Nuria Ribelles, Shoaib Afzal, Henrik Enghusen, Søren Astrup Jensen, Marie-Christine Etienne-Grimaldi, G. Milano, Mia Wadelius, Bengt Glimelius, Hans Garmo, Milena Gusella, Thierry Lecomte, Pierre Laurent‐Puig, Eva Martinez‐Balibrea, Rohini Sharma, Jesús García‐Foncillas, Zdeněk Kleibl, Alain Morel, Jean‐Pierre Pignon, Rachel Midgley, David Kerr, Ian D. Tomlinson
Pubblicazione 2014Revisão
Strumenti per la ricerca:
Soggetti correlati
Medicine
Cancer
Internal medicine
Oncology
Biology
Colorectal cancer
Gene
Genetics
Fluorouracil
Genotype
Pharmacogenetics
Pharmacology
Thymidylate synthase
Cancer research
Capecitabine
Chemotherapy
DPYD
Dihydropyrimidine dehydrogenase
Gastroenterology
Toxicity
Bevacizumab
Bioinformatics
Breast cancer
Metastasis
Allele
Cetuximab
Confidence interval
Environmental health
Exon
Genotyping